Yuantian Bio: Funding, Investors & Team (Sep 2026)
Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications.
Yuantian Bio has raised $14.8M across 2 funding rounds on record, the most recent a Series A of $14.8M announced in Jul 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Yuantian Bio Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Yuantian Bio Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Yuantian Bio announced a Seed in Sep 2025; the amount was not disclosed.
10 months later, a Series A of $14.8M was announced in Jul 2026.
Yuantian Bio Investors
10 investors are recorded in total; the 5 named above are those the record identifies.
Yuantian Bio Founders and Leadership Team
Contact details for the Yuantian Bio team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Yuantian Bio Funding Compared to Other Biotechnology Startups
Yuantian Bio's latest round of $14.8M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Yuantian Bio in Biotechnology and Tianjin
Companies Similar to Yuantian Bio
Protoga is a biotech firm that focused on the development of innovative microalgae biosynthesis technology.
NewLine researches phage feed additives to prevent livestock infections.
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic…
Salus BioMed is an innovative biomedical company that specializes in developing genetic sequencing technology…
Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the…
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of…
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The…
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer…
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Yuantian Bio Funding FAQs
What does Yuantian Bio do?
Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications.
How much funding has Yuantian Bio raised?
Yuantian Bio has raised $14.8M across 2 rounds on record. The most recent is a Series A of $14.8M announced in Jul 2026.
When did Yuantian Bio last raise funding?
Yuantian Bio's most recent funding round on record is a Series A of $14.8M, announced in Jul 2026.
Who has invested in Yuantian Bio?
Investors on record for Yuantian Bio include Haitang Fund, Shangshi Fund, Dalton Venture, Guotai Haitong Fund, SilkRoad GoldenBridge Capital. FundedIQ records 10 investors in total.
Who is the CEO of Yuantian Bio?
Shengping You is listed as CEO at Yuantian Bio.
Where is Yuantian Bio headquartered?
Yuantian Bio is based in Tianjin, China.
How many employees does Yuantian Bio have?
Yuantian Bio is in the 11-50 employee band.
When was Yuantian Bio founded?
Yuantian Bio was founded in 2022.
How does Yuantian Bio's funding compare to other Biotechnology startups?
Yuantian Bio's latest round of $14.8M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Yuantian Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Yuantian Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.